We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONON icon
2226
On Holding
ONON
$12.4B
$9.3K ﹤0.01%
200
+11
+6% +$474
ARRY icon
2227
Array Technologies
ARRY
$848M
$9.28K ﹤0.01%
1,006
-221
-18% -$1.9K
UNF icon
2228
Unifirst Corp
UNF
$5.38B
$9.26K ﹤0.01%
48
-30
-38% -$5.06K
RARE icon
2229
Ultragenyx Pharmaceutical
RARE
$2.65B
$9.2K ﹤0.01%
400
+264
+194% +$8.68K
ALEX
2230
DELISTED
Alexander & Baldwin
ALEX
$9.16K ﹤0.01%
444
-11,955
-96% -$208K
SITC icon
2231
SITE Centers
SITC
$232M
$9.13K ﹤0.01%
1,422
+308
+28% +$2.33K
FFIC
2232
DELISTED
Flushing Financial
FFIC
$9.09K ﹤0.01%
599
-47
-7% -$712
PZZA icon
2233
Papa John's
PZZA
$997M
$9.08K ﹤0.01%
236
-19
-7% -$839
SLDB icon
2234
Solid Biosciences
SLDB
$777M
$9.05K ﹤0.01%
1,605
+1,174
+272% +$6.36K
SPFI icon
2235
South Plains Financial
SPFI
$838M
$9K ﹤0.01%
232
INTR icon
2236
Inter&Co
INTR
$2.45B
$8.95K ﹤0.01%
1,055
TIC
2237
TIC Solutions Inc
TIC
$1.61B
$8.94K ﹤0.01%
884
-551
-38% -$6.13K
ZETA icon
2238
Zeta Global
ZETA
$5.17B
$8.85K ﹤0.01%
435
+84
+24% +$1.57K
LMB icon
2239
Limbach Holdings
LMB
$886M
$8.8K ﹤0.01%
113
-45
-28% -$3.7K
OGN icon
2240
Organon & Co
OGN
$3.56B
$8.73K ﹤0.01%
1,217
-9,606
-89% -$75.9K
SCHX icon
2241
Schwab US Large- Cap ETF
SCHX
$71.1B
$8.72K ﹤0.01%
324
FOXF icon
2242
Fox Factory Holding Corp
FOXF
$779M
$8.66K ﹤0.01%
506
-1,852
-79% -$35.3K
ACH
2243
Accendra Health
ACH
$247M
$8.63K ﹤0.01%
3,082
+440
+17% +$1.57K
MAMA icon
2244
Mama's Creations
MAMA
$825M
$8.62K ﹤0.01%
639
+430
+206% +$4.94K
DXPE icon
2245
DXP Enterprises
DXPE
$2.57B
$8.56K ﹤0.01%
78
+22
+39% +$2.4K
NX icon
2246
Quanex
NX
$863M
$8.52K ﹤0.01%
554
-277
-33% -$3.92K
ANAB icon
2247
AnaptysBio
ANAB
$1.59B
$8.48K ﹤0.01%
175
LW icon
2248
Lamb Weston
LW
$7.3B
$8.42K ﹤0.01%
201
LCID icon
2249
Lucid Motors
LCID
$2.54B
$8.37K ﹤0.01%
792
SHO icon
2250
Sunstone Hotel Investors
SHO
$2.2B
$8.33K ﹤0.01%
932

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.